BioCentury
ARTICLE | Clinical News

Immunomedics regulatory update

December 21, 1998 8:00 AM UTC

The FDA approved the company's Morris Plains, N.J., manufacturing facility and manufacturing process for its CEA-Scan arcitumomab diagnostic imaging product. Prior, IMMU manufactured products at its ...